Literature DB >> 22351659

Screening for efflux pump systems of bacteria by the new acridine orange agar method.

Ana Martins1, Leonard Amaral.   

Abstract

AIM: Development of a non-toxic, fluorescent-based, agar system for the screening of overexpressed bacterial efflux pump systems with common, inexpensive UV accessories.
MATERIALS AND METHODS: Wild type Gram-negative and positive bacteria expressing intrinsic efflux pumps and their progeny that overexpress a specific efflux pump were selected for evaluation of efflux pump activity in a Mueller-Hinton agar, containing increasing concentrations of the non-toxic fluorescent chromophore acridine orange (AO). The method is based on the same principle as the first-generation ethidium bromide method, according to which the concentration of the fluorescent dye that first produces fluorescence of the overlying bacterial colony represents the maximum concentration of the dye that the bacterium can extrude. The higher the concentration needed to produce fluorescence, the greater the ability of the bacterial efflux pump to extrude the dye.
RESULTS: Progeny of Escherichia coli, Salmonella enterica serovar Enteritidis and Staphylococcus aureus that over-expressed a given efflux pump fluoresced (i.e. accumulated AO) at concentrations of AO that were much greater than the ones required for the emission of fluorescence by their corresponding wild-type counterpart which expressed an intrinsic efflux pump.
CONCLUSION: The AO agar method readily identifies strains of Gram-negative and Gram-positive bacteria that overexpress efflux pump systems compared to their wild-type progeny.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22351659

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  6 in total

1.  Structure of the tripartite multidrug efflux pump AcrAB-TolC suggests an alternative assembly mode.

Authors:  Jin-Sik Kim; Hyeongseop Jeong; Saemee Song; Hye-Yeon Kim; Kangseok Lee; Jaekyung Hyun; Nam-Chul Ha
Journal:  Mol Cells       Date:  2015-01-15       Impact factor: 5.034

Review 2.  Survival of the Fittest: How Bacterial Pathogens Utilize Bile To Enhance Infection.

Authors:  Jeticia R Sistrunk; Kourtney P Nickerson; Rachael B Chanin; David A Rasko; Christina S Faherty
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

3.  Fluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coli.

Authors:  Wanida Phetsang; Ruby Pelingon; Mark S Butler; Sanjaya Kc; Miranda E Pitt; Geraldine Kaeslin; Matthew A Cooper; Mark A T Blaskovich
Journal:  ACS Infect Dis       Date:  2016-08-16       Impact factor: 5.084

4.  Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates.

Authors:  Amira M El-Ganiny; Hend A Kamel; Nehal E Yossef; Basem Mansour; Ahmed M El-Baz
Journal:  Saudi Pharm J       Date:  2022-01-19       Impact factor: 4.562

5.  Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them.

Authors:  Leonard Amaral; Ana Martins; Gabriella Spengler; Joseph Molnar
Journal:  Front Pharmacol       Date:  2014-01-03       Impact factor: 5.810

6.  Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery.

Authors:  E Armengol; O Domenech; E Fusté; I Pérez-Guillén; J H Borrell; J M Sierra; M Vinas
Journal:  Infect Drug Resist       Date:  2019-07-11       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.